Antineoplaston Therapy in Treating Patients With Ependymoma
Status:
Terminated
Trial end date:
2000-10-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Current therapies for patients with ependymoma provide limited benefit to the
patient. The anti-cancer properties of Antineoplaston therapy suggest that it may prove
beneficial in the treatment of patients with ependymoma .
PURPOSE: This study is being performed to determine the effects (good and bad) that
Antineoplaston therapy has on patients with ependymoma.